Physician profile
Joseph E Strauss
NPI 1003895111
$2,326.54
in general payments reported to CMS, 2019-2025
15 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $384 · 2021: $456 · 2022: $531 · 2023: $345 · 2024: $92.40 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,002.37 | 2019-2024 | T2 Alpha, Gamma, Mako |
| Smith+Nephew, INC. | $288.27 | 2019-2022 | |
| Encore Medical, Lp | $276.33 | 2019-2023 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $241.98 | 2020-2021 | |
| Native Surgical, LLC | $132.43 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $116.85 | 2021 | |
| Acumed LLC | $81.23 | 2020-2021 | |
| Orthofix Medical, INC. | $51.32 | 2020 | |
| Pacira Therapeutics, INC. | $30.24 | 2019 | |
| Amgen INC. | $26.62 | 2019 | |
| Organogenesis INC. | $19.89 | 2020 | |
| Endo Pharmaceuticals INC. | $16.22 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.12 | 2019 | |
| Arthrex, INC. | $14.21 | 2025 | |
| Bioventus LLC | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Strauss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.